[1] Greenberg SM,Vernooij MW,Cordonnier C,et al. Cerebral microbleeds: a guide to detection and interpretation[J]. Lancet Neurol, 2009,8(2):165-174. [2] Wilson D, Ambler G, Lee KJ, et al. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies[J]. Lancet Neurol, 2019,18(7):653-665. [3] Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study[J]. Neurology, 2008,70(14):1208-1214. [4] Charidimou A,Kakar P,Fox Z,et al. Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts[J]. Stroke, 2013,44(4):995-1001. [5] Mogi M, Horiuchi M. Clinical Interaction between brain and kidney in small vessel disease[J]. Cardiol Res Pract, 2011,2011:306189. [6] Oh MY, Lee H, Kim JS, et al. Cystatin C, a novel indicator of renalfunction, reflects severity of cerebral microbleeds[J]. BMC Neurol, 2014, 14(1):127. [7] Zhang JB,Jü XH,Wang J,et al. Serum cystatin C and cerebral microbleeds in patients with acute cerebral stroke[J]. J Clin Neurosci, 2014,21(2):268-273. [8] Zhang JB, Liu LF, Li ZG, et al. Associations between biomarkers of renal function with cerebral microbleeds in hypertensive patients[J]. Am J Hypertens, 2015,28(6):739-745. [9] Grubb A,Bjrk J,Nyman U,et al. Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation[J]. Scand J Clin Lab Invest, 2011,71(2):145-149. [10] 吴家玉, 熊冠泽, 丁福全, 等. 血清胱抑素C和尿NGAL联合检测在急性肾损伤病情评估及预后中的价值[J]. 中山大学学报(医学科学版), 2014,35(1):152-155,封3. [11] Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010,25(9):603-605. [12] Herzog R,álvarez-Pasquin MJ,Díaz C,et al. Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review[J]. BMC Public Health, 2013,13:154. [13] Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample[J]. BMC Med Res Methodol, 2005,5:13. [14] 季波, 李巧转. 急性脑梗死脑微出血的危险因素分析[J]. 现代诊断与治疗, 2015(20):4693-4694. [15] 成帅, 丁长霞. 血清CysC与脑梗死患者脑微出血的关系[J]. 中国实用神经疾病杂志, 2016,19(19):89-90. [16] 谢丽桔. 伴有急性脑梗死的脑微出血相关危险因素研究[D]. 福州: 福建医科大学, 2017. [17] 于文肖. 血脂对脑微出血及其严重程度的相关性研究[D]. 大连: 大连医科大学, 2018. [18] 何龙. 急性脑梗死患者早期肾功能指标与脑微出血的相关性研究[D]. 石家庄:河北大学, 2019. [19] 孙翠梅, 李强, 刘建强, 等. 血清胱抑素C与急性脑梗死患者脑微出血的相关性[J]. 脑与神经疾病杂志, 2019,27(11):696-699. [20] 张宇, 孔令博, 苗青, 等. 脑梗死患者肾小球滤过率预估值、胱抑素C水平与脑微出血的相关性分析[J]. 实用医院临床杂志, 2019,16(6):44-47. [21] 陈丝雨. 急性脑梗死合并脑微出血的相关危险因素临床分析[D]. 长春: 吉林大学, 2020. [22] 张多斌, 陈后勤, 蔡红星, 等. 缺血性脑卒中患者脑微出血的危险因素及血清CysC、NLR与脑微出血的关系[J]. 中国医药导报, 2020,17(35):38-41. [23] 钟锐, 周坤元, 王弘.脑梗死合并微出血与胱抑素C和同型半胱氨酸的相关性分析[J].心血管病防治知识, 2020,10(20):45-47. [24] Yakushiji Y, Wilson D, Ambler G, et al. Distribution of cerebral microbleeds in the East and West: individual participant meta-analysis[J]. Neurology, 2019,92(10):e1086-e1097. [25] Wu X, Yan J, Ye H, et al. Pre-treatment cerebral microbleeds and intracranial hemorrhage in patients with ischemic stroke receiving endovascular therapy: a systematic review and meta-analysis[J]. J Neurol, 2020,267(5):1227-1232. [26] Wilson D,Werring DJ. Antithrombotic therapy in patients with cerebral microbleeds[J]. Curr Opin Neurol, 2017,30(1):38-47. [27] Zhang J, Liu L, Sun H, et al. Cerebral microbleeds are associated with mild cognitive impairment in patients with hypertension[J]. J Am Heart Assoc, 2018,7(11):e008453. [28] 薛笑仙,刘利红,杨清成,等.青年缺血性脑卒中患者危险因素、临床特征及预后分析[J].实用预防医学,2021,28(4):499-502. [29] Altmann-Schneider I,Trompet S,de Craen AJ,et al. Cerebral microbleeds are predictive of mortality in the elderly[J]. Stroke, 2011,42(3):638-644. [30] Faraci FM, Brian JJ. Nitric oxide and the cerebral circulation[J]. Stroke, 1994,25(3):692-703. [31] Masuo K, Lambert GW, Esler MD, et al. The role of sympathetic nervous activity in renal injury and end-stage renal disease[J]. Hypertens Res, 2010,33(6):521-528. [32] Seo SW,Hwa LB,Kim EJ,et al. Clinical significance of microbleeds in subcortical vascular dementia[J]. Stroke, 2007,38(6):1949-1951. [33] Wu H,Du Q,Dai Q,et al. Cysteine protease cathepsins in atherosclerotic cardiovascular diseases[J]. J Atheroscler Thromb, 2018,25(2):111-123.
2022, Vol. 29 
